151 related articles for article (PubMed ID: 32915143)
1. FANCF hypomethylation is associated with colorectal cancer in Han Chinese.
Yu H; Pan R; Gao T; Wu D; Ying J; Duan S
Turk J Gastroenterol; 2020 Aug; 31(8):558-565. PubMed ID: 32915143
[TBL] [Abstract][Full Text] [Related]
2. Significant association between KDM1A promoter hypomethylation and colorectal cancer in Han Chinese.
Zhong J; Pan R; Ying X; Wu B; Zhou C; Wu D; Ying J; Duan S
Pathol Res Pract; 2019 Mar; 215(3):532-538. PubMed ID: 30638951
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
Wang Z; Li M; Lu S; Zhang Y; Wang H
Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
[TBL] [Abstract][Full Text] [Related]
4. Significant association of PRMT6 hypomethylation with colorectal cancer.
Pan R; Yu H; Dai J; Zhou C; Ying X; Zhong J; Zhao J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Duan S
J Clin Lab Anal; 2018 Nov; 32(9):e22590. PubMed ID: 29927001
[TBL] [Abstract][Full Text] [Related]
5. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.
Tokunaga E; Okada S; Kitao H; Shiotani S; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
Breast Cancer; 2011 Apr; 18(2):120-3. PubMed ID: 19813073
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.
Lim SL; Smith P; Syed N; Coens C; Wong H; van der Burg M; Szlosarek P; Crook T; Green JA
Br J Cancer; 2008 Apr; 98(8):1452-6. PubMed ID: 18414472
[TBL] [Abstract][Full Text] [Related]
8. SMYD3 promoter hypomethylation is associated with the risk of colorectal cancer.
Li B; Pan R; Zhou C; Dai J; Mao Y; Chen M; Huang T; Ying X; Hu H; Zhao J; Zhang W; Duan S
Future Oncol; 2018 Aug; 14(18):1825-1834. PubMed ID: 29969917
[TBL] [Abstract][Full Text] [Related]
9. Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line.
Parashar G; Parashar NC; Capalash N
Mol Cell Biochem; 2012 Jun; 365(1-2):29-35. PubMed ID: 22297615
[TBL] [Abstract][Full Text] [Related]
10. Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese.
Pan R; Zhou C; Dai J; Ying X; Yu H; Zhong J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Zhang W; Duan S
Exp Ther Med; 2018 Dec; 16(6):4983-4990. PubMed ID: 30542453
[TBL] [Abstract][Full Text] [Related]
11. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Wei M; Xu J; Dignam J; Nanda R; Sveen L; Fackenthal J; Grushko TA; Olopade OI
Breast Cancer Res Treat; 2008 Sep; 111(1):113-20. PubMed ID: 17932744
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of lncRNAs SNHG6, TRPM2-AS1, MIR4435-2HG, and hypomethylation of TRPM2-AS1 promoter in colorectal cancer.
Ghasemi T; Khalaj-Kondori M; Hosseinpour Feizi MA; Asadi P
Cell Biol Int; 2021 Dec; 45(12):2464-2478. PubMed ID: 34431156
[TBL] [Abstract][Full Text] [Related]
14. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.
Li Y; Zhao L; Sun H; Yu J; Li N; Liang J; Wang Y; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
PLoS One; 2012; 7(8):e44254. PubMed ID: 22952942
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
[TBL] [Abstract][Full Text] [Related]
16. Significant association between DHFR promoter methylation and ischemic stroke in a Chinese hypertensive population.
Hu J; Zhu H; Xu G; Chen Z; Li L; Wang S; Deng H; Bao X; Shen Z
J Clin Lab Anal; 2020 Aug; 34(8):e23322. PubMed ID: 32319147
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.
Zhao L; Li N; Yu JK; Tang HT; Li YL; He M; Yu ZJ; Bai XF; Zheng ZH; Wang EH; Wei MJ
Braz J Med Biol Res; 2014 Jan; 47(1):24-34. PubMed ID: 24345874
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer.
Chen C; Wang L; Liao Q; Huang Y; Ye H; Chen F; Xu L; Ye M; Duan S
Diagn Pathol; 2013 Dec; 8():199. PubMed ID: 24326135
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer.
Lin WH; Xiao J; Ye ZY; Wei DL; Zhai XH; Xu RH; Zeng ZL; Luo HY
Clin Epigenetics; 2021 Dec; 13(1):232. PubMed ID: 34961566
[TBL] [Abstract][Full Text] [Related]
20. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
